Search Results

Policy

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.

June 25, 2024

·

6 min read

Deals

Merck Animal Health to Acquire Elanco’s Aqua Business

Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species.

February 5, 2024

·

7 min read

Pharm Country

Merck Animal Health’s Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary Teams

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration with the American Veterinary Medical Association.

January 15, 2024

·

12 min read

Press Releases

Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus

September 25, 2024

·

5 min read

Postmarket research

Merck’s Former Asthma Blockbuster Singulair Could Be Linked to Mental Health Problems: Reuters

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma therapy montelukast to adverse neuropsychiatric effects.

November 22, 2024

·

2 min read

·

Tristan Manalac

Infusion bag and injection syringe in the blue background, 3d rendering. Digital drawing.

Clinical research

Merck’s Subcutaneous Keytruda Meets Expectations in Phase III

Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster goes off patent in 2028.

November 19, 2024

·

2 min read

·

Annalee Armstrong

South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.

GLP-1

Merck Joins Obesity Pill Race With Up to $2B Hansoh Deal

The Hansoh deal will let Merck compete in the crowded oral GLP-1 space alongside fellow pharma giants Eli Lilly, Novo Nordisk and Roche.

December 18, 2024

·

2 min read

·

Tristan Manalac

Vaccines

CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64

The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.

October 24, 2024

·

2 min read

·

Tristan Manalac

BioMidwest

ByoPlanet and Merck Animal Health Announce Partnership with USEF

ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. and Merck Animal Health are proud to announce a groundbreaking partnership with The United States Equestrian Federation to advance animal health through innovative products and technologies.

May 23, 2023

·

5 min read

Business

Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health

ByoPlanet is excited to announce the establishment of a comprehensive one-year distribution agreement with Merck Animal Health, a global leader in animal health solutions and a division of Merck & Co.

May 19, 2023

·

5 min read